In November 2025, Novo Nordisk and Eli Lilly both reached similar deals with the Trump administration to sell the lowest dose of oral GLP-1 medications for $149 per month out of pocket
Empire Medical Training MIC & Lipotropic Injections for Weight Loss: A Clinical Guide (adjunct positioning, evidence note)
Long-term success depends on the system around the prescription: education, coaching, and support that help habits stick over time
As GLP-1 medications become more widely used for metabolic health and weight management, interest in needle-free alternatives has surged
Potential Side Effects, Safety Profile, and Regulatory Status of BPC 157 In preclinical studies, BPC 157 caused mild local irritation at the site of administration, which was the most commonly reported side effect but did not appear to lead to long-term issues